Targeted Drug administration, also known as Smart Drug Delivery, is a technique for administering a patient's medications in such a way that the medication is more concentrated in some areas of the body than others. This method of delivery is mostly based on nanomedicine, which aims to use medication administration via nanoparticles to counter the drawbacks of traditional drug delivery. These drug-loaded nanoparticles would be directed to specific areas of the body that only contain sick tissue, avoiding contact with healthy tissue. A Targeted Medicine Delivery System aims to extend, localise, target, and engage with the sick tissue in a safe manner. While the targeted releasing system delivers the medicine in a dose form, the traditional drug delivery method involves the drug being absorbed through a biological membrane. The patient will need to take fewer doses more frequently, the medicine will have a more consistent impact, there will be fewer adverse effects, and there will be less volatility in the drug levels in the blood. The system's drawbacks include a hefty price tag that makes productivity more challenging and a limited capacity to change doses is concentrated in particular areas of the body more than others. This method of delivery is mostly based on Nanomedicine, which aims to use medication administration using nanoparticles to address the drawbacks of traditional drug delivery. Only those areas of the body's damaged tissue would be exposed to these drug-loaded nanoparticles, protecting surrounding healthy tissue. A targeted medication delivery system aims for a safe extension, localization, targeting, and interaction with the sick tissue. Instead of being absorbed through a biological membrane as is the case with the traditional drug delivery method, the targeted releasing mechanism delivers the medication in dosage form. There will be fewer adverse effects, less need for frequent dosage administration, less fluctuation in blood drug levels, and more consistent effects of the prescription. The system's drawbacks include a high price that hinders productivity and a limited capacity to change doses. The effectiveness of regeneration approaches has grown with the emergence of personalised drug delivery systems. The device works by 50 to keep the body's required medication levels in the tissue and plasma, preventing any drug-related damage to healthy tissue. Because the medicine distribution system is so linked, it requires specialists from several domains to collaborate, including pharmacists, biologists, and engineers.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation